Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegileridine vs sufentanil PCIA for postoperative adverse reactions after cesarean section
ChiCTR2600123056Phase 4Recruiting
- Sponsor
- Guangzhou Women and Children’s Medical Center
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tegileridine in postoperative pain (2 arms), sponsored by Guangzhou Women and Children’s Medical Center. Primary endpoints: Incidence of postoperative nausea and vomiting, PCA usage and 1 more. Started Apr 2026; status: recruiting.
02
Drugs
tegileridine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2600123056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600123056.